Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna MRNA revealed 8 unusual trades.
Delving into the details, we found 62% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $148,500, and 5 were calls, valued at $787,414.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $90.0 and $120.0 for Moderna, spanning the last three months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Moderna's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale activity within a strike price range from $90.0 to $120.0 in the last 30 days.
Moderna Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| MRNA | CALL | TRADE | BULLISH | 03/15/24 | $120.00 | $665.0K | 593 | 6 |
| MRNA | PUT | TRADE | BULLISH | 01/12/24 | $107.00 | $81.8K | 99 | 430 |
| MRNA | PUT | SWEEP | BULLISH | 01/05/24 | $109.00 | $34.2K | 583 | 283 |
| MRNA | CALL | SWEEP | BEARISH | 02/16/24 | $90.00 | $33.5K | 410 | 23 |
| MRNA | PUT | TRADE | BEARISH | 02/16/24 | $105.00 | $32.5K | 356 | 63 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Moderna's Current Market Status
- With a volume of 915,430, the price of MRNA is down -0.64% at $107.88.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 49 days.
What Analysts Are Saying About Moderna
In the last month, 1 experts released ratings on this stock with an average target price of $142.0.
- An analyst from Oppenheimer has elevated its stance to Outperform, setting a new price target at $142.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
